Marcella Masciullo

Marcella Masciullo

Auto-generated profile, based on publicly available information

Marcella Masciullo

NeuroRobot Lab, Fondazione Santa Lucia, Rome, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2019 in The Cerebellum
Verified
Journal Article
Open access
PDF file
GAGeorgios P. D. Argyropoulos
Georgios P. D. Argyropoulos
KDKim van Dun
Kim van Dun
MAMichael Adamaszek
Michael Adamaszek
MLMaria Leggio
Maria Leggio
Mario MantoMario Manto
Mario Manto
JSJeremy D. Schmahmann
Jeremy D. Schmahmann
Sporadically advocated over the last two centuries, a cerebellar role in cognition and affect has been rigorously established in the past few decades. In the clinical domain, such progress is epitomized by the “cerebellar cognitive affective syndrome” (“CCAS”) or “Schmahmann syndrome.” Introduced in the late 1990s, CCAS reflects a constellation of cerebellar-induced sequelae, comprising deficits in executive function, visuospatial cognition, emotion–affect, and language, over and above speech. The CCAS thus offers excellent grounds to investigate the functional topography of the cerebellum, and, ultimately, illustrate the precise mechanisms by which the cerebellum modulates cognition and affect. The primary objective of this task force paper is thus to stimulate further research in this area. After providing an up-to-date overview of the fundamental findings on cerebellar neurocognition, the paper substantiates the concept of CCAS with recent evidence from different scientific angles, promotes awareness of the CCAS as a clinical entity, and examines our current insight into the therapeutic options available. The paper finally identifies topics of divergence and outstanding questions for further research.

1 July 2013 in The Lancet Neurology
Verified
Journal Article
Closed access
HJHeike Jacobi
Heike Jacobi
KRKathrin Reetz
Kathrin Reetz
SMSophie Tezenas du Montcel
Sophie Tezenas du Montcel
PBPeter Bauer
Peter Bauer
CMCaterina Mariotti
Caterina Mariotti
TKThomas Klockgether
Thomas Klockgether

29 April 2014 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
SMSophie Tezenas du Montcel
Sophie Tezenas du Montcel
ADAlexandra Durr
Alexandra Durr
MRMaria Rakowicz
Maria Rakowicz
LNLorenzo Nanetti
Lorenzo Nanetti
PCPerrine Charles
Perrine Charles
JGJean-Louis Golmard
Jean-Louis Golmard
Background The most common spinocerebellar ataxias (SCA)—SCA1, SCA2, SCA3, and SCA6—are caused by (CAG)n repeat expansion. While the number of repeats of the coding (CAG)n expansions is correlated with the age at onset, there are no appropriate models that include both affected and preclinical carriers allowing for the prediction of age at onset. Methods We combined data from two major European cohorts of SCA1, SCA2, SCA3, and SCA6 mutation carriers: 1187 affected individuals from the EUROSCA registry and 123 preclinical individuals from the RISCA cohort. For each SCA genotype, a regression model was fitted using a log-normal distribution for age at onset with the repeat length of the alleles as covariates. From these models, we calculated expected age at onset from birth and conditionally that this age is greater than the current age. Results For SCA2 and SCA3 genotypes, the expanded allele was a significant predictor of age at onset (−0.105±0.005 and −0.056±0.003) while for SCA1 and SCA6 genotypes both the size of the expanded and normal alleles were significant (expanded: −0.049±0.002 and −0.090±0.009, respectively; normal: +0.013±0.005 and −0.029±0.010, respectively). According to the model, we indicated the median values (90% critical region) and the expectancy (SD) of the predicted age at onset for each SCA genotype according to the CAG repeat size and current age. Conclusions These estimations can be valuable in clinical and research. However, results need to be confirmed in other independent cohorts and in future longitudinal studies. ClinicalTrials.gov, number NCT01037777 and NCT00136630 for the French patients.

8 January 2021 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Verified
Journal Article
Open access
CMC. Meijneke
C. Meijneke
GOG. van Oort
G. van Oort
VSVictor IJzebrand Sluiter
Victor IJzebrand Sluiter
EAE. van Asseldonk
E. van Asseldonk
NTNevio Luigi Tagliamonte
Nevio Luigi Tagliamonte
HKHerman Van Der Kooij
Herman Van Der Kooij
In this paper, we present the design, control, and preliminary evaluation of the Symbitron exoskeleton, a lower limb modular exoskeleton developed for people with a spinal cord injury. The mechanical and electrical configuration and the controller can be personalized to accommodate differences in impairments among individuals with spinal cord injuries (SCI). In hardware, this personalization is accomplished by a modular approach that allows the reconfiguration of a lower-limb exoskeleton with ultimately eight powered series actuated (SEA) joints and high fidelity torque control. For SCI individuals with an incomplete lesion and sufficient hip control, we applied a trajectory-free neuromuscular control (NMC) strategy and used the exoskeleton in the ankle-knee configuration. For complete SCI individuals, we used a combination of a NMC and an impedance based trajectory tracking strategy with the exoskeleton in the ankle-knee-hip configuration. Results of a preliminary evaluation of the developed hardware and software showed that SCI individuals with an incomplete lesion could naturally vary their walking speed and step length and walked faster compared to walking without the device. SCI individuals with a complete lesion, who could not walk without support, were able to walk with the device and with the support of crutches that included a push-button for step initiation Our results demonstrate that an exoskeleton with modular hardware and control allows SCI individuals with limited or no lower limb function to receive tailored support and regain mobility.

16 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Giorgio TascaGiorgio Tasca
Giorgio Tasca
MMMauro Monforte
Mauro Monforte
EIElisabetta Iannaccone
Elisabetta Iannaccone
FLFrancesco Laschena
Francesco Laschena
POPierfrancesco Ottaviani
Pierfrancesco Ottaviani
EREnzo Ricci
Enzo Ricci
In Facioscapulohumeral muscular dystrophy (FSHD), the upper girdle is early involved and often difficult to assess only relying on physical examination. Our aim was to evaluate the pattern and degree of involvement of upper girdle muscles in FSHD compared with other muscle diseases with scapular girdle impairment. We propose an MRI protocol evaluating neck and upper girdle muscles. One hundred-eight consecutive symptomatic FSHD patients and 45 patients affected by muscular dystrophies and myopathies with prominent upper girdle involvement underwent this protocol. Acquired scans were retrospectively analyzed. The trapezius (100% of the patients) and serratus anterior (85% of the patients) were the most and earliest affected muscles in FSHD, followed by the latissimus dorsi and pectoralis major, whilst spinati and subscapularis (involved in less than 4% of the patients) were consistently spared even in late disease stages. Asymmetry and hyperintensities on short-tau inversion recovery (STIR) sequences were common features, and STIR hyperintensities could also be found in muscles not showing signs of fatty replacement. The overall involvement appears to be disease-specific in FSHD as it significantly differed from that encountered in the other myopathies. The detailed knowledge of single muscle involvement provides useful information for correctly evaluating patients' motor function and to set a baseline for natural history studies. Upper girdle imaging can also be used as an additional tool helpful in supporting the diagnosis of FSHD in unclear situations, and may contribute with hints on the currently largely unknown molecular pathogenesis of this disease.

1 October 2012 in Neuromuscular Disorders
Verified
Journal Article
Closed access
Giorgio TascaGiorgio Tasca
Giorgio Tasca
EIElisabetta Iannaccone
Elisabetta Iannaccone
MMMauro Monforte
Mauro Monforte
MMMarcella Masciullo
Marcella Masciullo
FBFlaviana Bianco
Flaviana Bianco
EREnzo Ricci
Enzo Ricci